Anastasios Maniakas, M.D., Ph.D., FRCSC
Department of Head and Neck Surgery, Division of Surgery
About Dr. Anastasios Maniakas
Anastasios Maniakas, M.D., PhD., is an Assistant Professor, Tenure Track, in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. Dr. Maniakas received his undergraduate, master’s, and doctoral degrees from McGill University, and his medical doctorate from the University of Montreal. He completed his residency at the University of Montreal followed by a fellowship in head and neck surgical oncology at The University of Texas MD Anderson Cancer Center. His clinical expertise is in head and neck cancers, with an emphasis on thyroid disease, oral cavity cancer, skin cancers, and salivary gland neoplasms. Dr. Maniakas’ research interests focus on translational research, developing unique patient-derived xenograft models utilized in understanding cancer pathogenesis and novel drug therapy development. Furthermore, Dr. Maniakas is investigating the effect of the microbiome in the development, progression, and recurrence of cancer in his patient population. Lastly, he is co-leading a global randomized trial evaluating the effect of photoimmunotherapy in locoregionally advanced head and neck squamous cell carcinoma.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Tenure Track, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Tenure Track, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2022 | McGill University, Montreal, CA, Experimental Surgery, Ph.D |
| 2018 | McGill University, Montreal, CA, Experimental Surgery, M.Sc |
| 2013 | University of Montreal, Montreal, CA, MD |
| 2009 | McGill University, Montreal, CA, Microbiology & Immunology, Minor in Classical Studies, B.Sc |
Postgraduate Training
| 2019-2020 | Research Fellowship, Head and Neck Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2019 | Clinical Fellowship, Head and Neck Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Global Clinical Scholars Research Training Program, Harvard Medical School, Boston, Massachusetts |
| 2013-2018 | Clinical Residency, Otolaryngology - Head & Neck Surgery, University of Montreal, Montreal |
Licenses & Certifications
| 2021 | Texas Medical License |
| 2020 | College des Medecins du Quebec |
| 2020 | Royal College of Physicians and Surgeons of Canada |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, University of Montreal, Montreal, QC, 2020 - 2021
Administrative Appointments/Responsibilities
Member, The University of Texas MD Anderson Cancer Center, 2025 - Present
Director, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Head & Neck Surgery Leader, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Other Professional Positions
Clinical-Surgeon-Scientist, Hopital Maisonneuve-Rosemont, Centre de Recherche - Hopital Maisonneuve-Rosemont, Montreal, 2020 - 2021
OTL-HNS Resident Coordinator, University of Montreal Health Centre, Montreal, 2018
OTL-HNS Resident Coordinator, Hôpital Maisonneuve-Rosemont, Montreal, 2017 - 2018
OTL-HNS Resident Coordinator, Hopital CHU Sainte-Justine, Montreal, 2016
OTL-HNS Resident Coordinator, Hopital Hôtel-Dieu de Montréal, Montreal, 2016 - 2017
Extramural Institutional Committee Activities
Member, Bylaws Committee, International Thyroid Oncology Group (ITOG) Leadership, 2025 - Present
Member, Head & Neck Previously Untreated Locally Advanced Working Group, NRG Oncology Leadership, 2023 - Present
Member, Head & Neck Rare Tumor Working Group, NRG Oncology Leadership, 2023 - Present
Member, International Advisory Service Committee, American Head and Neck Society Leadership, 2022 - Present
Member, History and Archives Committee, American Thyroid Association Leadership, 2022 - Present
Member, Endocrine Section Committee, American Head and Neck Society Leadership, 2021 - Present
Member, Endocrine Surgery Committee, American Academy of Otolaryngology Leadership, 2021 - 2023
Consultant, Outcomes Research and Evidence-Based Medicine, American Academy of Otolaryngology Leadership, 2021 - 2023
Consultant, Outcomes Research and Evidence-Based Medicine, American Academy of Otolaryngology Leadership, 2021 - 2023
Editorial Activities
Co-Editor, Frontiers in Oncology – Head and Neck Cancer, Topic: The Role of the Microbiome in Head and Neck Cancer, 2023 - Present
Honors & Awards
| 2025 | ENT Research All-Star 2025, AVANT-GARDE Health |
| 2024 | Perfect Score Provider for Fiscal Year 2024, Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2024 | Top 1% Nationally (USA) Fiscal Year 2024, Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) |
| 2024 | Full Membership Nomination, Sigma Xi Scientific Research Honor Society |
| 2024 | ENT Research All-Star 2024, Avant-Garde Health |
| 2023 | Outstanding Poster - Unusual ATC-like malignancies, ATA |
| 2022 | AAO-HNSF Best of Orals – Azithromycin Type 1 inflammation, AAO-HNSF |
| 2022 | AAO-HNSF Best of Orals – Engineering for success after ESS, AAO-HNSF |
| 2021 | 5th Annual Naso-Sano Award in Collaboration with the ERS, European Rhinologic Society |
| 2021 | Best Abstract Session - European Rhinologic Society, European Rhinologic Society |
| 2021 | University of Montreal - Department of Surgery Research Grant - 10,000 CAD |
| 2021 | Oral Presentation Award - Impact of COVID-19 pandemic on AOM complications, University of Montreal |
| 2019 | McGill University GREAT Award - 400 CAD |
| 2019 | American Thyroid Association Trainee Grant - 2,000 USD, American Thyroid Association |
| 2019 | NRG Oncology Travel Award - 1,000 USD, NRG Oncology |
| 2019 | CIHR Vanier CGS Doctoral Award - 150,000 CAD, Canadian Institutes of Health Research |
| 2019 | FRQS Research Fellowship Award - 110,000 CAD, Fonds de Recherche du Quebec - Sante |
| 2018 | McGill University Nominee for Vanier Canada Graduate Scholarships, McGill University |
| 2018 | Dean's Honor List - University of Montreal, University of Montreal |
| 2018 | Daniel-Tasse Award Department of Surgery- 500 CAD, University of Montreal |
| 2018 | 1st Prize Department of Surgery Research Day- 300 CAD, University of Montreal |
| 2018 | Fellowship and Recruitment Award - Department of Surgery - 5,000 CAD, University of Montreal |
| 2018 | European Rhinologic Society Junior Fellowship Grant - 750 EUR |
| 2017 | Detweiler Fellowship Award - 7,500 CAD, Royal College of Canada |
| 2017 | McGill University GREAT Award - 360 CAD |
| 2017 | Hellenic Scholarships Foundation Scholar - 2,000 CAD |
| 2017 | Poliquin Resident Research Competition Finalist, Canadian Society of Otolaryngology |
| 2016 | American Thyroid Association Trainee Award - 2,050 CAD, American Thyroid Association |
| 2016 | University of Montreal Resident Association Travel Award - 300 CAD |
| 2016 | University of Montreal OTL-HNS Residency 1st Prize - 1,000 CAD, University of Montreal |
| 2016 | 1st Prize Short Oral Presentation, University of Montreal Division of OTL-HNS Resident Research Day |
| 2016 | 1st Prize Video Competition, University of Montreal Department of Surgery Scientific Meeting |
| 2016 | 1st Prize Resident Video competition, University of Montreal Division of OTL-HNS |
| 2016 | 2nd Prize Resident Video Competition, University of Montreal Division of OTL-HNS |
| 2015 | CRCHUM Graduate Degree Excellence Award - 1,500 CAD, University of Montreal Research Center |
| 2015 | McGill University GREAT Award - 400 CAD |
| 2015 | International Thyroid Congress Trainee Award - 1,500 USD, American Thyroid Association |
| 2015 | AAO-HNS Resident Leadership Award - 500 USD |
| 2015 | Harvard Medical School - Distinction |
| 2015 | 3rd Prize University of Montreal Department of Surgery Resident Award |
| 2015 | 2nd Prize University of Montreal Department of Surgery - Podium Presentation Award |
| 2015 | Frederick Banting and Charles Best CGS-M - 17,500 CAD, Canadian Institutes of Health Research |
| 2015 | Master's Training Grant for Professionals - 62,000 CAD, Fonds de Recherche du Quebec - Sante (FRQS) |
| 2015 | McGill University International Travel Fund Award - 2,000 CAD |
| 2015 | CRCHUM Master Degree Training Grant/Award - 1,000 CAD, University of Montreal Research Center |
| 2015 | McGill University GREAT Award - 500 CAD |
| 2014 | Investigator-Initiated Research Grant Award - 39,989 CAD, Pfizer |
| 2014 | University of Montreal Advanced Trauma Life Support Excellence Award - 200 CAD, University of Montreal |
| 2014 | Global Clinical Scholars Research Training Program Scholarship - 2,725 USD, Harvard Medical School |
| 2013 | Poster competition finalist, Canadian Society of Otolaryngology-Head & Neck Surgery |
| 2012 | American Thyroid Association Fellows Clinical Grant - 1,000 USD |
| 2009 | McGill University Academy of Athens Prize - 500 CAD |
| 2009 | McGill University Great Distinction |
| 2008 | McGill University Dean's Honor List |
| 2008 | Hellenic Scholarships Foundation Scholar - 2,000 CAD |
| 2007 | Meakins-Christie Laboratories - Summer Studentship Award - 3,500 CAD, McGill University |
| 2004 - 2006 | Marianopolis College Honor Roll and Dean's List |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. TNM Staging/Diagnostic Evaluation of the Head and Neck Cancer Patient. Invited. Oral Oncology Symposium. Houston, TX, US.
- 2024. Medullary Thyroid Cancer. Invited. Head and Neck Didactic Lectures. Houston, Texas, US.
- 2024. Surgical Management of Medullary Thyroid Cancer. Invited. Texas Endocrinology Association 2024 Annual Meeting. Austin, TX, US.
- 2024. Characterization of RAS-mutant anaplastic thyroid cancer. Poster. UT MD Anderson Department of Internal Medicine Annual Research Retreat. Houston, Texas, US.
- 2023. Surgical Management of DTC, Thyroid Cancer Management in the Era of Precision Medicine. Invited. Houston, Texas, US.
- 2023. The role of imaging in head and neck endocrine surgical planning. Invited. MDA Head and Neck Ultrasound Educational Lecture Series. Houston, TX, US.
- 2022. Single center experience with the combination of lenvatinib and pembrolizumab for the treatment of anaplastic thyroid cancer. Poster. MD Anderson Division of Internal Medicine Research Retreat. Houston, Texas, US.
National Presentations
- 2025. Gender and race disparity in patients undergoing surgery for papillary thyroid cancer. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Indianapolis, IN, US.
- 2025. Central and lateral lymph node metastasis in papillary thyroid cancer according to primary tumor location. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Indianapolis, IN, US.
- 2025. Surgical management of isthmus-confined papillary thyroid carcinoma: a single institution retrospective cohort study. Poster. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Preclinical evaluation of the pan-RAF inhibitor JZP815 in anaplastic thyroid carcinoma cell lines and patient-derived xenografts. Poster. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Lenvatinib plus pembrolizumab in anaplastic thyroid cancer: a phase 2 single center trial. Invited. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Neoadjuvant targeted therapy for locally advanced differentiated thyroid carcinoma. Invited. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Addition of VEGF or mTOR Inhibition to BRAF-targeted Therapy in BRAFV600E-Mutated ATC (BRAFm-ATC). Invited. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Neoadjuvant treatment with selpercatinib for RET-altered thyroid cancer: a multicenter phase 2 clinical trial. Invited. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. Clinicopathologic features of papillary thyroid cancer-to-anaplastic thyroid carcinoma transformation. Invited. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. High central compartment nodal metastases from PTC: a potential surgical blind spot in patients undergoing central neck dissection. Poster. American Thyroid Association 94th Annual Meeting. Scottsdale, AZ, US.
- 2025. A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC). Poster. ASCO Annual Meeting. Chicago, IL, US.
- 2025. The shifting landscape of germline RET pathogenic variants: a cross-sectional analysis of nearly one million patients. Invited. American Association of Endocrine Surgeons. Milwaukee, WI, US.
- 2025. Tracheoesophageal fistula secondary to diffuse B-cell lymphoma during pregnancy. Poster. AATS Annual Meeting. Seattle, WA, US.
- 2025. Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for BRAFV600E-mutated anaplastic thyroid cancer: A multicenter phase 2 trial. Invited. ASCO Annual Meeting. Chicago, IL, US.
- 2025. Neoadjuvant BRAF/MEK inhibitor therapy and immunotherapy for BRAFV600E-mutated anaplastic thyroid cancers. Invited. American Head and Neck Society Annual Meeting. New Orleans, LA, US.
- 2025. Development and characterization of BRAF/MEK inhibitor resistant anaplastic thyroid carcinoma patient-derived xenograft and cell line models. Poster. AACR Annual Meeting. Chicago, IL, US.
- 2025. Novel anaplastic thyroid carcinoma patient-derived xenograft models and cell line. Poster. AACR Annual Meeting. Chicago, IL, US.
- 2024. Effect of PI3K pathway activating mutations on response to BRAF/MEK inhibitor therapy in BRAFV600E mutated anaplastic thyroid cancer. Invited. American Thyroid Association 93rd Annual Meeting. Chicago, IL, US.
- 2024. Efficacy and Safety of Selective RET Inhibitors in Hereditary Medullary Thyroid Carcinoma. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Clinicopathological Features of Advanced, RAS-driven Differentiated Thyroid Carcinoma (DTC). Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Adjuvant pembrolizumab after multimodal therapy for anaplastic thyroid cancer. Invited. American Thyroid Association 93rd Annual Meeting. Chicago, IL, US.
- 2024. Characterization of RAS-mutant Anaplastic Thyroid Carcinoma (ATC). Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Immune Checkpoint Inhibitor Therapy for Locally Advanced or Metastatic Periocular Merkel Cell Carcinoma. Invited. ASOPRS 2024 Fall Scientific Symposium. Chicago, IL, US.
- 2024. BRAF treatment response determinants in anaplastic thyroid cancer studied through single cell DNA and RNA sequencing. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Challenges and factors affecting successful patient-derived xenograft model establishment for anaplastic thyroid cancer. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Targeting the MAPK and DNA Repair Pathways in Poorly Differentiated and Anaplastic Thyroid Cancer Cells. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Role of the ETV5/p38 Signaling Axis in BRAF-Mutated Anaplastic Thyroid Cancers. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Consolidative radiotherapy for oligometastatic and oligoprogressive anaplastic thyroid carcinoma: the potential utility of local therapy for limited distant sites. Poster. 2024 American Thyroid Association Annual Meeting. Chicago, IL, US.
- 2024. Clinical implications of the gut microbiome in anaplastic thyroid cancer. Invited. European Thyroid Association Annual Meeting. Athens, GR.
- 2024. Oral Presentations Endocrine Surgery. Panelist. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Miami, FL, US.
- 2024. Masters of Surgery Head and Neck Surgery. Panelist. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Miami, FL, US.
- 2024. Development and characterization of advanced thyroid cancer PDX pre-clinical models. Invited. International Thyroid Oncology Group Annual Meeting. Jacksonville, FL, US.
- 2023. Shared Decision-Making principles in the non-surgical management of thyroid nodules. Panelist. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Nashville, TN, US.
- 2023. Shared Decision-Making Principles in the Non-Surgical Management of Thyroid Nodules, American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Panelist. Nashville, TN, US.
- 2023. ESS for CRS Does Not Reduce CST1 Expression in Asthmatics. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Nashville, TN, US.
- 2023. Survival outcomes of temporal bone squamous cell carcinoma: systematic review. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Nashville, TN, US.
- 2023. Survival outcomes of temporal bone squamous cell carcinoma: systematic review. Invited. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. Nashville, TN, US.
- 2023. Podium Presentation: Checkpoint Inhibition in Addition to Dabrafenib + Trametinib (DT) for BRAFV600E Mutated Anaplastic Thyroid Carcinoma (BRAFm-ATC): Real-World Experience. 2023 American Thyroid Association Annual Meeting. Washington, DC, US.
- 2023. Unusual Thyroid Pathologies: Presentation, Management, And Clinical Outcomes. Poster. American Thyroid Association 92nd Annual Meeting. Washington, DC, US.
- 2022. Anaplastic and poorly differentiated thyroid cancer. Invited. Baylor College of Medicine Head and Neck Didactic Lectures. Houston, TX, US.
- 2022. Engineering for success after ESS: Decrease in T1 inflammation, epithelial restoration, and reduction in S. aureus. Philadelphia, PA, US.
- 2022. Azithromycin reduces type 1 inflammation and induces epithelial restoration after ESS. Philadelphia, PA, US.
- 2022. Advances and challenges in anaplastic thyroid cancer management. Invited. 6th Balkan Society of ORL-HNS. Ohrid, Northern Macedonia.
- 2022. Podium Presentation: Single center experience with the combination of lenvatinib and pembrolizumab for the treatment of anaplastic thyroid cancer. Atlanta, GA, US.
- 2022. Single center experience with the combination of lenvatinib and pembrolizumab for the treatment of anaplastic thyroid cancer. Poster. Endo Society Annual Meeting. Atlanta, GA, US.
- 2022. Developing a career in clinical research. Invited. Boston, MA, US.
- 2022. TNM Staging/Diagnostic Evaluation of the Head and Neck Cancer Patient. Invited. Oral Oncology Symposium. Houston, TX, US.
- 2021. Decreasing indications for postoperative adjuvant radiation therapy in locoregionally-advanced medullary thyroid cancer. Poster. Virtual Meeting, US.
- 2021. Development and characterization of six novel anaplastic thyroid cancer patient-derived xenograft models. Poster. Chicago, IL, US.
- 2021. Targeting tumor metabolism through lactate dehydrogenase A inhibits tumor progression in anaplastic thyroid cancer xenografts. Poster. Chicago, IL, US.
- 2020. Collapse of bacterial diversity of the sinus microbiome characterizes poor evolution after ESS for CRS, Virtual, US.
- 2020. In vivo drug response evaluation in anaplastic thyroid cancer patient-derived tumor xenografts following high-throughput screening. Poster. San Diego, CA, US.
- 2020. Collapse of bacterial diversity of the sinus microbiome characterizes poor evolution after ESS for CRS. Poster. Cambridge, MA, US.
- 2019. Revolutionizing the therapeutic landscape of a deadly disease. Chicago, IL, US.
- 2019. Prior cancers among patients newly diagnosed with anaplastic thyroid carcinoma: prevalence and impact on survival. Poster. Chicago, IL, US.
- 2019. Increased abundance of Staphylococcus aureus characterizes microbiome in refractory CRS patients. New Orleans, LA, US.
- 2019. Collapse of bacterial diversity of the sinus microbiome differentiates poor from good evolution after ESS for CRS. New Orleans, LA, US.
- 2018. Impact of socioeconomic status on thyroid cancer presentation and outcome: a retrospective multicenter cohort study. Poster. CANNECT. Washington, DC, US.
- 2018. Office-based stapes surgery: long-term outcomes. Poster. Atlanta, GA, US.
- 2018. Rapid Tissue Identification in Thyroid Surgery using Optical Coherence Tomography. Poster. Washington, DC, US.
- 2017. Elderly patients with chronic sinusitis have increased sinus dysbiosis. Chicago, IL, US.
- 2016. International survey on peri-operative practices in thyroid surgery. Poster. San Diego, CA, US.
- 2016. In vivo rapid tissue identification with optical coherence tomography in thyroid and parathyroid surgery. Poster. American Thyroid Association 86th Annual Meeting. San Diego, CA, US.
- 2016. An evaluation of SPARC protein as a serum biomarker of epithelial-to-mesenchymal transition in CRS. San Diega, CA, US.
- 2016. Eustachian tube symptoms are frequent in CRS and respond well to ESS. San Diego, CA, US.
- 2016. Can a panel of serum inflammatory biomarkers predict endoscopic sinus surgery outcomes for chronic rhinosinusitis?. San Diego, CA, US.
- 2016. Rapid tissue optical biopsy in thyroid and parathyroid surgery. Poster. San Diego, CA, US.
- 2016. Real life trial in high-risk chronic rhinosinusitis patients. Poster. San Diego, CA, US.
- 2016. Optical coherence tomography as a tool for rapid neck tissue identification during thyroid surgery. 36th Annual American Society of Laser Medicine & Surgery Meeting. Boston, MA, US.
- 2016. Simultaneous multi-scale microscopy as a potential dedicated tool for intra-operative parathyroid identification during thyroid surgery. San Francisco, CA, US.
- 2015. Peri-operative practices in thyroid surgery: an international survey. Poster. Buena Vista, FL, US.
- 2015. Risk factors for failure in the surgical management of frontal sinusitis in cystic fibrosis patients. Poster. Dallas, TX, US.
- 2015. Cost effective selection between swab and tissue biopsy for conventional sinus cultures in chronic rhinosinusitis patients. Dallas, TX, US.
- 2015. Outcomes analysis of the surgical management of frontal sinusitis in cystic fibrosis patients. Poster. COSM, Combined Otolaryngology Spring Meetings. Boston, MA, US.
- 2013. Preoperative features in superior canal dehiscent patients who do not need a surgical treatment. Orlando, FL, US.
- 2012. Preoperative thyroglobulin levels and sentinel lymph node biopsy outcomes in well differentiated thyroid carcinoma: Is there a correlation?. Poster. Washington, DC, US.
- 2012. Effectiveness of azithromycin as an add-on therapy to steroid irrigations in high-risk post-endoscopic sinus surgery patients. Washington, DC, US.
- 2009. Genetic ablation of CC family chemokine receptor 2 (CCR2) mitigates muscle dysfunction in the dystrophic (Mdx) mouse diaphragm. American Thoracic Society International Conference. San Diego, CA, US.
International Presentations
- 2025. Prognostic significance of BRAFV600E status in papillary thyroid cancer. Poster. 17th International Thyroid Congress. Rio de Janeiro, BR.
- 2025. Intraoperative management of recurrent laryngeal nerve invasion in head and neck surgery. Invited. Universitas Indonesia Guest Lecture Series. Jakarta, ID.
- 2025. Management of advanced thyroid cancers in the era of neoadjuvant therapy. Invited. Department of Otorhinolaryngology Grand Rounds. Zurich, CH.
- 2024. GRASSROOT-Global real-world data in patients with advanced thyroid cancer on standard of care and specialized interventions-registry of oncologic outcomes with testing and treatment. Poster. ESMO ASIA Congress 2024, SG.
- 2024. Efficacy of adding Lenvatinib to BRAF-directed therapy at progression in BRAFV600E-mutated anaplastic thyroid carcinoma. Poster. European Thyroid Association Annual Meeting. Athens, GR.
- 2024. Circulating tumor DNA in HPV+ oropharyngeal carcinoma – is this the new frontier?. Invited. 13th Balkan ORL-HNS Society meeting. Istanbul, TR.
- 2024. Advanced thyroid cancer management. Invited. 13th Balkan ORL-HNS Society meeting. Istanbul, TR.
- 2024. Surgical planning and maximizing imaging utilization in head and neck surgery. Visiting. University of British Columbia Division of Otolaryngology-Head & Neck Surgery Grand Rounds. Vancouver, CA.
- 2023. Podium Presentation: Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Podium Presentation: The Protective Role Of Adjuvant Radiotherapy In Low And Intermediate-Grade Major Salivary Gland Malignancies: A Canadian Head & Neck Collaborative Research Initiative Study. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Podium Presentation: Continued long-term response following two cycles of PD-L1 inhibitor in stage IVC BRAF-negative anaplastic thyroid cancer - a case report. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Podium Presentation: Oncologic Significance of Therapeutic Delays in Oral Cavity Cancer: A Canadian Multi-Center Study. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Podium Presentation: Patterns for recurrence in patients with papillary thyroid carcinoma: A 23-year follow-up analysis. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Perioperative antibiotics in uncomplicated thyroid and parathyroid surgery: is there still an indication for systematic use?. Poster. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. Poster Presentation: BRAF V600E-mutant papillary thyroid cancer with loss of differentiation is characterized by dysregulation in metabolic pathways. Invited. American Head and Neck Society 11th International Conference. Montreal, CA.
- 2023. The Integration of Targeted Therapy and Surgery in Advanced Thyroid Cancer Trials. Invited. ITOG 2023 Annual Meeting. Naples, IT.
- 2023. Anaplastic Thyroid Cancer - a new era for one of the deadliest diseases. Visiting. Scientific Postgraduate Program for Residents in Otolaryngology, GR.
- 2023. French translation and validation of the Neck Dissection Impairment Index, a quality of life measure for the surgical oncology population. IFOS Meeting. Dubai, AE.
- 2022. Advances and challenges in aggressive thyroid cancer. Invited. Rome, IT.
- 2022. Keynote Speaker,. Visiting. 4th Annual Dr. Stuart D. Archibald Annual Update and Resident's Research Day, CA.
- 2022. Podium Presentation: Management and Outcomes of Anaplastic Thyroid Cancer in the Era of Targeted Therapy. Invited. Canada's Experience. Vancouver, CA.
- 2022. BRAF/MEK Inhibitor Plus Immunotherapy for BRAFV600E-mutated Anaplastic Thyroid Carcinoma (BRAFm-ATC). Invited. American Thyroid Association Annual Meeting. Montreal, CA.
- 2022. French translation and validation of the Neck Dissection Impairment Index, a quality of life measure for the surgical oncology population. Invited. Quebec Otolaryngology-Head and Neck Surgery Annual Meeting, CA.
- 2022. Management and Outcomes of Anaplastic Thyroid Cancer in the Era of Targeted Therapy: Canada's Experience. Poster. Montreal, CA.
- 2021. Increased Staphylococcus aureus prevalence characterizes the elderly CRS population. Gatineau, CA.
- 2021. Evaluation of the impact of the COVID-19 pandemic on the incidence of acute otitis media complications. Gatineau, CA.
- 2021. CRS epithelial cells show increased susceptibility to TNF-induced senescence. Gatineau, CA.
- 2021. Aggressiveness and Curability of Newly Diagnosed Head and Neck Cancers During the COVID-19 Pandemic. Gatineau, CA.
- 2021. Azithromycin reduces Staphylococcus aureus in refractory CRS patients: a 16S RNA analysis. Thessaloniki, GR.
- 2021. Evaluation of the impact of the COVID-19 pandemic on the incidence of acute otitis media complications. Poster, US.
- 2021. Efficacy of low-dose azithromycin in refractory chronic rhinosinusitis following endoscopic sinus surgery and corticosteroid nasal irrigations: a double-blind, randomized, placebo-controlled trial. Thessaloniki, GR.
- 2021. Collapse of bacterial diversity of the sinus microbiome characterizes poor evolution after ESS for CRS. Thessaloniki, GR.
- 2021. Impact of COVID-19 pandemic on AOM complications. Montreal, CA.
- 2021. High-activity TSLP genotype correlates with low Staphylococcus aureus carriage. Montreal, CA.
- 2019. Rapid Tissue Identification in Thyroid Surgery using Optical Coherence Tomography: a Prospective Sensitivity, Specificity and Reliability Analysis. Winner at Poliquin Competition. Edmonton, CA.
- 2018. Predictive pharmacogenomics in personalized medicine for chronic rhinosinusitis, CA.
- 2018. Rôle de la tomographie par cohérence optique dans la chirurgie de la thyroïde, CA.
- 2018. Office-based stapes surgery: efficacy and safety. Poliquin Competition. Quebec City, CA.
- 2018. Intraoperative Detection of Nodal Metastasis in Thyroid Surgery Using Optical Coherence Tomography: A Pilot Study. Poster. Quebec City, CA.
- 2018. Identifying preoperative factors that can influence the extent of thyroid surgery. Poster. Quebec City, CA.
- 2018. Staphylococcus aureus positive culture swabs: the unsung hero predicting endoscopic sinus surgery failure and disease recurrence. London, GB.
- 2017. Regional variation in initial surgical treatment of well-differentiated thyroid cancer: Is there an impact on recurrence?. Poster. CANNECT. Victoria, CA.
- 2017. Revision surgery in chronic sinusitis: a significant negative prognostic factor in disease outcome. La Malbaie, CA.
- 2017. Atypical localization of a respiratory adenomatous hamartoma: a clinical case and systematic review of the literature. La Malbaie, CA.
- 2017. Subannular tubes in the pediatric population: Clinical outcomes following more than 2 years follow-up. Saskatoon, CA.
- 2017. Revision surgery in chronic sinusitis: a significant negative prognostic factor in disease outcome. Poliquin Competition. Saskatoon, CA.
- 2017. Elderly patients with chronic sinusitis have increased sinus dysbiosis. Montreal, CA.
- 2017. Subannular tubes in the pediatric population: Clinical outcomes following more than 2 years follow-up. Montreal, CA.
- 2017. Double-blind placebo-controlled randomized clinical trial of azithromycin for patients failing endoscopic sinus surgery for chronic rhinosinusitis. Montreal, CA.
- 2016. Meta-analysis on the clinical outcomes between conservative management and microsurgery in patients with intralabyrinthine schwannomas. Montreal, CA.
- 2016. In vivo rapid tissue identification with optical coherence tomography in thyroid and parathyroid surgery. Montreal, CA.
- 2016. An evaluation of SPARC protein as a serum biomarker of epithelial-to-mesenchymal transition in CRS. Montreal, CA.
- 2016. Effect of Eustachian tube obliteration on rhinoliquorrhea in translabyrinthine vestibular schwannoma excision. Paris, FR.
- 2016. Effect of Eustachian tube obliteration on rhinoliquorrhea in translabyrinthine vestibular schwannoma excision. Montreal, CA.
- 2016. Increased serum IgA levels in chronic rhinosinusitis. Stockholm, SE.
- 2016. How does your thyroid practice compare to the rest of the world? Taking a look at the new ATA guidelines and the first international thyroid surgery survey. Charlottetown, CA.
- 2016. Intra-operative rapid tissue identification in thyroid and parathyroid surgery: a novel high-resolution optical biopsy tool. Charlottetown, CA.
- 2016. Meta-analysis on the clinical outcomes between conservative management and microsurgery in patients with intralabyrinthine schwannomas. Charlottetown, CA.
- 2016. International survey on peri-operative practices in thyroid surgery. Lille, FR.
- 2016. Intra-operative rapid tissue identification in thyroid and parathyroid surgery. 15th International Francophone Oto-Rhino-Laryngology and Head & Neck Surgery Society Meeting. Lille, FR.
- 2016. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery. Montreal, CA.
- 2016. Rapid tissue identification in thyroid and parathyroid surgery: a high resolution optical biopsy tool. Montreal, US.
- 2015. International survey on peri-operative practices in thyroid surgery. Quebec City, CA.
- 2015. Conventional sinus culture versus tissue biopsy culture intra-operatively: is there a clinical advantage?. Quebec City, CA.
- 2015. Management of refractory chronic rhinosinusitis using a simplified treatment algorithm: personalizing treatment in the absence of biomarkers. Quebec City, CA.
- 2015. Management of refractory chronic rhinosinusitis using a simplified treatment algorithm: personalizing treatment in the absence of biomarkers. Winnipeg, CA.
- 2015. International survey on peri-operative practices in thyroid surgery. Montreal, CA.
- 2014. Meta-analysis on the clinical outcomes between conservative management and microsurgery in patients with intralabyrinthine schwannomas. Paris, FR.
- 2014. Meta-analysis on the clinical outcomes between conservative management and microsurgery in patients with intralabyrinthine schwannomas. Montreal, CA.
- 2014. Neurofibromatosis Type 2 vestibular schwannoma treatment: a review of the literature, trends and outcomes. Ottawa, CA.
- 2013. North American survey on HPV and p16 status assessment for Head and Neck Squamous Cell Carcinoma. Montreal, CA.
- 2013. Neurofibromatosis Type 2 vestibular schwannoma treatment: a review of the literature, trends and outcomes. Montreal, CA.
- 2013. Creating an interdisciplinary database on function and quality of life in head and neck cancers. Montreal, CA.
- 2013. Common features in superior canal dehiscent patients who decline surgical treatment. Paris, FR.
- 2013. Common features in superior canal dehiscent patients who decline surgical treatment. Montreal, CA.
- 2013. North American Survey on HPV and p16 testing in head and neck cancer. Poster. Vancouver, CA.
- 2013. Tumor classification in Well Differentiated Thyroid Carcinoma and Sentinel Lymph Node Biopsy Outcomes: a Direct Correlation. Poster. Banff, CA.
- 2013. Preoperative features in superior canal dehiscent patients who do not need a surgical treatment. Poster. Banff, CA.
- 2013. North American Survey on HPV and p16 testing in head and neck cancer. Poster. Banff, CA.
- 2013. Delaying partial stapedectomy for otosclerosis: Effects on long-term hearing outcomes following surgery. Poster. Banff, CA.
- 2013. Growth factors expression in hyaluronic acid fat graft myringoplasty. Banff, CA.
- 2013. North American survey on HPV and p16 status assessment for Head and Neck Squamous Cell Carcinoma. Montreal, CA.
- 2013. Neurofibromatosis Type 2 vestibular schwannoma treatment: a review of the literature, trends and outcomes. Montreal, CA.
- 2013. Effectiveness of azithromycin as an add-on therapy to steroid irrigations in high-risk post-endoscopic sinus surgery patients. Montreal, CA.
- 2012. Preoperative thyroglobulin levels and sentinel lymph node biopsy outcomes in well differentiated thyroid carcinoma: Is there a correlation?. Quebec City, CA.
- 2012. North American survey on HPV and p16 status assessment for Head and Neck Squamous Cell Carcinoma. Quebec City, CA.
- 2012. Microsurgery versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Paris, FR.
- 2012. Microsurgery versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Quebec City, CA.
- 2012. Effectiveness of azithromycin as an add-on therapy to steroid irrigations in high-risk post-endoscopic sinus surgery patients. Quebec City, CA.
- 2012. Effectiveness of azithromycin as an add-on therapy to steroid irrigations in high-risk post-endoscopic sinus surgery patients. Quebec City, US.
- 2012. Tumor classification in Well Differentiated Thyroid Carcinoma and Sentinel Lymph Node Biopsy Outcomes: a Direct Correlation. Poster. Quebec City, CA.
- 2012. Superior canal dehiscence syndrome : clinical manifestations and radiologic correlations. Toronto, CA.
- 2012. Preoperative thyroglobulin levels and sentinel lymph node biopsy outcomes in well differentiated thyroid carcinoma: Is there a correlation?. Montreal, CA.
- 2012. Preoperative thyroglobulin levels and sentinel lymph node biopsy outcomes in well differentiated thyroid carcinoma: Is there a correlation?. Toronto, CA.
- 2012. Post-operative radioactive iodine in low-risk thyroid cancer patients: a modified approach incorporating sentinel lymph node biopsies. Poster. Toronto, CA.
- 2012. Microsurgery versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Toronto, CA.
- 2012. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Toronto, CA.
- 2012. Microsurgery versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Montreal, CA.
- 2011. Superior canal dehiscence syndrome : clinical manifestations and radiologic correlations. Montreal, CA.
- 2011. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Montreal, CA.
- 2011. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Paris, FR.
- 2011. Cortisol, a case study presentation. Montreal, CA.
- 2011. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years of follow-up. Montreal, CA.
- 2010. Poster Presentation: Genetic ablation of CC class chemokine receptor 2 (CCR2) improves myofiber structure and function in the dystrophic (mdx) diaphragm. Ottawa, CA.
- 2009. Family chemokine receptor 2 (CCR2) is involved in the pathogens of muscle degeneration in the dystrophic diaphragm. Quebec City, CA.
Formal Peers
- 2023. Anaplastic Thyroid Cancer - a new era for one of the deadliest diseases. Visiting, GR.
- 2022. Advances and challenges in aggressive thyroid cancer. Invited, IT.
- 2022. Keynote Speaker. Visiting, Ontario, CA.
- 2022. Advances and challenges in anaplastic thyroid cancer management. Invited, MK.
- 2022. TNM Staging/Diagnostic Evaluation of the Head and Neck Cancer Patient. Invited. Houston, TX, US.
- 2021. Developing a career in clinical research. Invited. Boston, MA, US.
- 2021. Development and utilization of robust preclinical animal models in anaplastic thyroid carcinoma. Invited. Montreal, Quebec, CA.
- 2014. Meta-analyses of the medical literature in the management of vestibular schwannomas. Invited. Montreal, Quebec, CA.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | American Thyroid Association Thyroid Research Grant |
| Funding Source: | ThyCa: Thyroid Cancer Survivors’ Association, Inc |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | Radiofrequency and graphene nanoparticle activation in HN cancer |
| Funding Source: | NABORS Industries |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | MD Anderson Head and Neck SPORE: Oral Cavity (spORAL) |
| Funding Source: | MD Anderson Cancer Center |
| Role: | Co-PI |
| Date: | 2025 - Present |
| Title: | Effect of SGK1 inhibitor in advanced thyroid cancer |
| Funding Source: | Petrick Foundation |
| Role: | Co-PI |
| Date: | 2024 - 2028 |
| Title: | ASP-1929 Photoimmunotherapy + Pembrolizumab in LRR HNSCC |
| Funding Source: | Rakuten Medical |
| Role: | Co-PI |
| Date: | 2024 - Present |
| Title: | ImpACT: improving treatment strategies for anaplastic thyroid cancer through integration of novel therapies and assessment of tumor response |
| Funding Source: | NIH |
| Role: | Co-I |
| Date: | 2024 - 2026 |
| Title: | JZP815: A pan-RAF kinase inhibitor for preclinical testing on patient derived xenografts |
| Funding Source: | MDA Young Investigator Advanced Thyroid Cancer Grant, ATC Multidisciplinary Petrick Research Program |
| Role: | Mentor |
| Date: | 2024 - Present |
| Title: | Utilizing Advanced Thyroid Cancer PDX Models for Novel Therapeutics Development JZP-815 |
| Funding Source: | JAZZ Pharmaceuticals |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Development of a BRAF/MEK inhibitor resistant PDX model |
| Funding Source: | AHNS CORE |
| Role: | PI |
| Date: | 2024 - Present |
| Title: | Utilizing Advanced Thyroid Cancer PDX Models for Novel Therapeutics Development– THRV-1257 |
| Funding Source: | Thryv Therapeutics Inc |
| Role: | Co-PI |
| Date: | 2024 - 2026 |
| Title: | Utilizing Advanced Thyroid Cancer PDX Models for Novel Therapeutics Development |
| Funding Source: | ITOG |
| Role: | PI |
| Date: | 2024 - Present |
| Title: | Utilizing PDX models for Novel Therapeutics Development in Advanced Thyroid Cancer |
| Funding Source: | ATA Thyroid Research Grant Program |
| Role: | PI |
| Date: | 2023 - 2028 |
| Title: | Start-up Grant: Development of a translational program and drug development program for advanced thyroid cancer |
| Funding Source: | University of Texas MD Anderson |
| Role: | PI |
| Date: | 2023 - 2024 |
| Title: | Development of a BRAF/MEK inhibitor resistant PDX model |
| Funding Source: | Petrick Foundation |
| Role: | PI |
| Date: | 2019 - 2021 |
| Title: | Azithromycin in refractory |
| Funding Source: | CRS: a DBRCT, CIHR VANIER CGS Award |
| Role: | PI |
| Date: | 2019 - 2021 |
| Title: | PDX model development in aggressive thyroid cancers |
| Funding Source: | Fonds de Recherche du Quebec - Sante |
| Role: | PI |
| Date: | 2015 - 2017 |
| Title: | Long-term low-dose macrolides in refractory CRS |
| Funding Source: | Fonds de Recherche du Quebec – Sante |
| Role: | PI |
| Date: | 2015 - 2016 |
| Title: | Long-term low-dose macrolides in refractory CRS |
| Funding Source: | Frederick Banting and Charles Best CGS-M |
| Role: | PI |
| Date: | 2014 - 2018 |
| Title: | Investigator-Initiated Research Grant - Drug Repurposing in Otolaryngologic diseases |
| Funding Source: | Pfizer |
| Role: | Co-PI |
Selected Publications
Peer-Reviewed Articles
- Fournier I, Bandi AV, Hamidi S, Iyer P, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Waguespack SG, Basmaci UN, Williams MD, Mansour M, Monroe MG, Gross ND, Goepfert RP, Perrier ND, Banuchi V, Wang JR, Maniakas A, Zafereo ME. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head Neck, 2025. e-Pub 2025. PMID: 40891104.
- Hawes EE, Banuchi VE, Maniakas A, Wang JR, Graham PH, Diersing JD, Busaidy NL, Cabanillas ME, Dadu R, Hamidi S, Iyer P, Waguespack SG, Ahmed S, Alizada S, Belcastro A, Alsharif R, Hu MI, Zafereo ME. Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques. Head Neck, 2025. e-Pub 2025. PMID: 40747656.
- Cabanillas ME, Busaidy NL, Gunn GB, Iyer PC, Ferrarotto R, Gule-Monroe M, Maniakas A, Williams MD, Liu S, Fellman B, Spiotto M, Hamidi S, Akhave N, Lee A, Wang JR, de Sousa L, Marczyk VR, Zafereo M, Dadu R. Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid 35(7):763-770, 2025. e-Pub 2025. PMID: 40609521.
- Hamidi S, Maniakas A, Akhave NS, Banuchi VE, Busaidy NL, Dadu R, Ferrarotto R, Guise TA, Hofmann MC, Hosseini SM, Hu MI, Iyer PC, Mansour M, Marczyk VR, Roy-Chowdhuri S, Sherman SI, Sousa LG, Wang JR, Williams MD, Zafereo ME, Waguespack SG, Cabanillas ME. Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues. J Clin Endocrinol Metab, 2025. e-Pub 2025. PMID: 40568752.
- Hamidi S, Dadu R, Iyer PC, Busaidy NL, Maniakas A, Wang JR, Banuchi VE, Hosseini SM, Williams MD, Zafereo ME, Cabanillas ME. Circulating Tumor DNA as a Biomarker for Disease Surveillance in Anaplastic Thyroid Cancer. JCO Precis Oncol 9:e2500067, 2025. e-Pub 2025. PMID: 40570261.
- Kaffey Z, Mirbahaeddin S, Wahid K, Kamel S, Vouffo M, Otun AO, Belal Z, Aponte Wesson RA, Carriere PP, Dede C, Maniakas A, Goepfert RP, Garden AS, Lee A, Choi KY, Christensen JM, Lincoln C, Manzar GS, Dudzinski SO, Thomas R, Mehrens H, Cardoso RC, Schellingerhout D, Watson E, Chen MM, Lai SY, Fuller CD, Moreno AC, Humbert-Vidan L. Radiographic classification of mandibular osteoradionecrosis: A blinded prospective multi-disciplinary interobserver diagnostic performance study. Radiother Oncol 208:110917, 2025. e-Pub 2025. PMID: 40320174.
- Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi CS, Makitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM Jr, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Prospective blinded human inter-observer performance evaluation. Cancer 131(7):e35815, 2025. e-Pub 2025. PMID: 40159431.
- Houl JH, Bagheri-Yarmand R, Kunnimalaiyaan M, Miranda Mendez P, Kidd JL, Dadbin A, Jurado Ruiz A, Parekh PA, Henderson YC, Chari NS, Thennavan AT, Powell RT, Stephan CC, Zhao X, Maniakas A, Nurieva R, Busaidy NL, Cabanillas ME, Dadu R, Zafereo M, Wang JR, Lai SY, Hofmann MC. Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells. bioRxiv, 2025. e-Pub 2025. PMID: 40027641.
- Hong X, Quimby AE, Mavedatnia D, Pickett AT, Corsten M, Zhang T, Tohme A, Johnson-Obaseki S, Khalil C, Khoury M, Eskander A, Noroozi H, Goldstein D, De Almeida J, Fowler J, MacNeil SD, Nichols AC, Dort J, Hart R, Matthews W, Christopoulos A, Dayan G, Bahig H, Hier MP, Sultanem K, Morand GB, Routhier-Chevrier B, Zhang ZS, Belzile M, Laref H, Olivier MJ, Maniakas A. Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research Initiative. J Otolaryngol Head Neck Surg 54:19160216251351562, 2025. e-Pub 2025. PMID: 40844831.
- Marczyk VR, Fazeli S, Dadu R, Busaidy NL, Iyer P, Hu MI, Sherman SI, Hamidi S, Hosseini SM, Williams MD, Ahmed S, Routbort MJ, Luthra R, Roy-Chowdhuri S, San Lucas FA, Patel KP, Hong DS, Zafereo M, Wang JR, Maniakas A, Waguespack SG, Cabanillas ME. NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy. JCO Precis Oncol 9:e2400321, 2025. e-Pub 2025. PMID: 39983078.
- Hamidi S, Yedururi S, Hu MI, Busaidy NL, Sherman SI, Jimenez C, Grubbs EG, Maniakas A, Zafereo ME, Subbiah V, Waguespack SG. Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid, 2024. e-Pub 2024. PMID: 39630530.
- Dagher SA, Learned KO, Dagher R, Wang JR, Zhao X, Hosseini SM, Maniakas A, Cabanillas ME, Busaidy NL, Dadu R, Iyer P, Zafereo ME, Khalaf AM. [18F]-Fluorodeoxyglucose Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma Following BRAF-Targeted Therapy. AJNR Am J Neuroradiol, 2024. e-Pub 2024. PMID: 39572200.
- Bronk JK, Augustyn A, Mohamed ASR, David Fuller C, Garden AS, Moreno AC, Lee A, Morrison WH, Phan J, Reddy JP, Rosenthal DI, Spiotto MT, Frank SJ, Dadu R, Busaidy N, Zafereo M, Wang JR, Maniakas A, Ferrarotto R, Iyer PC, Cabanillas ME, Gunn GB. Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer. Radiother Oncol 202:110602, 2024. e-Pub 2024. PMID: 39489425.
- Hohlbein J, Fan J, Goldberg H, Lu T, Maniakas A, Wong M, Esmaeli B. Immune Checkpoint Inhibitor Therapy for Periocular Merkel Cell Carcinoma. Ophthalmology, 2024. e-Pub 2024. PMID: 39127410.
- Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol, 2024. e-Pub 2024. PMID: 38990526.
- Awad A, Pal K, Maniakas A, Zafereo M, Grosu H, Cabanillas M, Chen SR. Carotid blowout into the trachea: unusual entity with unexpected management outcome. J Neurointerv Surg 16(7):743-746, 2024. e-Pub 2024. PMID: 37532452.
- Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Makitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM Jr, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2024. e-Pub 2024. PMID: 36865096.
- Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma. Thyroid 34(3):336-346, 2024. e-Pub 2024. PMID: 38226606.
- Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
- Sedillot-Daniel E, Melkane A, Chiesa C, Fakhry N, Young VN, Smith LJ, Lechien JR, Guertin L, Olivier MJ, Maniakas A, Jun Lin R, Bissada E, Christopoulos A, Ayad T, Leclerc AA. Development of the "LAser Surgical skills Evaluation for Residents" (LASER) Scale Through a Modified Delphi Method. J Otolaryngol Head Neck Surg 53:19160216241278654, 2024. e-Pub 2024. PMID: 39417890.
- Khoury M, Guertin W, Hao C, Saltychev M, Ayad T, Bissada E, Christopoulos A, Moubayed S, Olivier MJ, Chepeha D, Lai SY, Maniakas A. Canadian French Translation and Validation of the Neck Dissection Impairment Index: A Quality of Life Measure for the Surgical Oncology Population. J Otolaryngol Head Neck Surg 53:19160216241263852, 2024. e-Pub 2024. PMID: 38899627.
- Renteria AE, Maniakas A, Pelletier A, Filali-Mouhim A, Brochiero E, Valera FCP, Adam D, Mfuna LE, Desrosiers M. Utilization of Transcriptomic Profiling to Identify Molecular Markers Predicting Successful Recovery Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis. Otolaryngol Head Neck Surg 169(6):1662-1673, 2023. e-Pub 2023. PMID: 37622488.
- Dayan GS, Bahig H, Johnson-Obaseki S, Eskander A, Hong X, Chandarana S, de Almeida JR, Nichols AC, Hier M, Belzile M, Gaudet M, Dort J, Matthews TW, Hart R, Goldstein DP, Yao CMKL, Hosni A, MacNeil D, Fowler J, Higgins K, Khalil C, Khoury M, Mlynarek AM, Morand G, Sultanem K, Maniakas A, Ayad T, Christopoulos A. Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer. JAMA Otolaryngol Head Neck Surg 149(11):961-969, 2023. e-Pub 2023. PMID: 37422839.
- Gupta MK, Misariu AM, Saydy N, Nichols AC, Laxague F, Eskander A, Li H, Weisbrod N, Pasternak JD, Golbon B, Jin E, van Uum SHM, Brassard M, Levesque F, Sadeghi N, Subramaniam T, Mlynarek AM, Morand GB, Fortier PH, Fradet L, Ghaznavi S, Chandarana SP, Prisman E, Ayad T, Christopoulos A, Davies JC, Rajaraman M, Corsten M, Rajaraman K, Maniakas A. A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience. Thyroid 33(11):1374-1377, 2023. e-Pub 2023. PMID: 37725592.
- Morand GB, Eskander A, Fu R, de Almeida J, Goldstein D, Noroozi H, Hosni A, Seikaly H, Tabet P, Pyne JM, Matthews TW, Dort J, Nakoneshny S, Christopoulos A, Bahig H, Johnson-Obaseki S, Hua N, Gaudet M, Jooya A, Nichols A, Laxague F, Cecchini M, Du J, Shapiro J, Karam I, Dziegielewski PT, Hanubal K, Erovic B, Grasl S, Davies J, Monteiro E, Gete M, Witterick I, Sadeghi N, Richardson K, Shenouda G, Maniakas A, Landry V, Gupta M, Zhou K, Mlynarek AM, Pusztaszeri M, Sultanem K, Hier MP. The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative. Cancer 129(20):3263-3274, 2023. e-Pub 2023. PMID: 37401841.
- Renteria AE, Valera FCP, Maniakas A, Adam D, Filali-Mouhim A, Ruffin M, Mfuna LE, Brochiero E, Desrosiers MY. Azithromycin Mechanisms of Action in CRS Include Epithelial Barrier Restoration and Type 1 Inflammation Reduction. Otolaryngol Head Neck Surg 169(4):1055-1063, 2023. e-Pub 2023. PMID: 37125631.
- Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF(V600E) Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
- Chen YH, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, Williams MD, Lai SY, Busaidy N, Dadu R, Zafereo ME, Wang JR. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid 33(3):321-329, 2023. e-Pub 2023. PMID: 36511380.
- Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NL. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck 45(3):547-554, 2023. e-Pub 2023. PMID: 36524701.
- Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2023. PMID: 36503246.
- Lampasona G, Noujaim J, Gologan O, Berdugo J, Maniakas A. Locoregionally Advanced, BRAF V600L-Positive, Mucosal Melanoma of the Hypopharynx Treated With a Combination of BRAF and MEK Inhibitors. JCO Precis Oncol 6:e2100561, 2022. e-Pub 2022. PMID: 35709404.
- Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab 106(11):e4652-e4665, 2021. e-Pub 2021. PMID: 34147031.
- Henderson YC, Mohamed ASR, Maniakas A, Chen Y, Powell RT, Peng S, Cardenas M, Williams MD, Bell D, Zafereo ME, Wang RJ, Scherer SE, Wheeler DA, Cabanillas ME, Hofmann MC, Johnson FM, Stephan CC, Sandulache V, Lai SY. A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab 106(10):2962-2978, 2021. e-Pub 2021. PMID: 34120183.
- Chen Y, Maniakas A, Tan L, Cui M, Le X, Niedzielski JS, Michel KA, Harlan CJ, Lu W, Henderson YC, Mohamed ASR, Lorenzi PL, Putluri N, Bankson JA, Sandulache VC, Lai SY. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer. Br J Cancer 124(10):1670-1679, 2021. e-Pub 2021. PMID: 33742144.
- Maniakas A, Asmar MH, Renteria AE, Nayan S, Alromaih S, Endam LM, Sampalis JS, Desrosiers M. Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial. Int Forum Allergy Rhinol 11(4):747-754, 2021. e-Pub 2021. PMID: 32929891.
- Renteria AE, Maniakas A, Mfuna LE, Asmar MH, Gonzalez E, Desrosiers M. Low-dose and long-term azithromycin significantly decreases Staphylococcus aureus in the microbiome of refractory CRS patients. Int Forum Allergy Rhinol 11(2):93-105, 2021. e-Pub 2021. PMID: 32713109.
- Srivastava A, Maniakas A, Myers J, Chambers MS, Cardoso R. Reconstruction of intraoral oncologic surgical defects with Integra((R)) bilayer wound matrix. Clin Case Rep 9(1):213-219, 2021. e-Pub 2021. PMID: 33489162.
- Renteria AE, Mfuna Endam L, Adam D, Filali-Mouhim A, Maniakas A, Rousseau S, Brochiero E, Gallo S, Desrosiers M. Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2. Am J Respir Cell Mol Biol 63(5):707-709, 2020. e-Pub 2020. PMID: 32857620.
- Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol 6(9):1397-1404, 2020. e-Pub 2020. PMID: 32761153.
- Zahedi A, Bondaz L, Rajaraman M, Leslie WD, Jefford C, Young JE, Pathak KA, Bureau Y, Rachinsky I, Badreddine M, De Brabandere S, Fong H, Maniakas A, Van Uum S. Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation. Thyroid 30(6):871-877, 2020. e-Pub 2020. PMID: 31524071.
- Yang N, Beaudoin PL, Nguyen M, Maillé H, Maniakas A, Saliba I. Subannular ventilation tubes in the pediatric population: Clinical outcomes of over 1000 insertions. Int J Pediatr Otorhinolaryngol 131:109859, 2020. e-Pub 2020. PMID: 31918244.
- Yang N, Boudoux C, De Montigny E, Maniakas A, Gologan O, Madore WJ, Khullar S, Guertin L, Christopoulos A, Bissada E, Ayad T. Rapid head and neck tissue identification in thyroid and parathyroid surgery using optical coherence tomography. Head Neck 41(12):4171-4180, 2019. e-Pub 2019. PMID: 31571306.
- Voizard B, Maniakas A, Saliba I. Office-Based Stapes Surgery. Otolaryngol Head Neck Surg 161(6):1018-1026, 2019. e-Pub 2019. PMID: 31570044.
- Asmar MH, Gaudreau A, Maniakas A, Mfuna Endam L, Desrosiers M. An Evaluation of SPARC Protein as a Serum Biomarker of Chronic Rhinosinusitis. Otolaryngol Head Neck Surg 160(1):158-164, 2019. e-Pub 2019. PMID: 30274534.
- Maniakas A, Desrosiers M, Asmar MH, Al Falasi M, Endam LM, Hopkins C, Philpott C, Erskine S, Smith R, Kilty S. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery. Rhinology 56(2):118-121, 2018. e-Pub 2018. PMID: 29509831.
- Maniakas A, Asmar MH, Renteria Flores AE, Nayan S, Alromaih S, Mfuna Endam L, Desrosiers MY. Staphylococcus aureus on Sinus Culture Is Associated With Recurrence of Chronic Rhinosinusitis After Endoscopic Sinus Surgery. Front Cell Infect Microbiol 8:150, 2018. e-Pub 2018. PMID: 29868506.
- Moderie C, Maniakas A, Moumdjian R, Alhabib SF, Saliba I. Eustachian Tube Obliteration and its Effect on Rhinoliquorrhea in Translabyrinthine Vestibular Schwannoma Excision. J Int Adv Otol 13(2):191-194, 2017. e-Pub 2017. PMID: 28816691.
- Maniakas A, Christopoulos A, Bissada E, Guertin L, Olivier MJ, Malaise J, Ayad T. Perioperative practices in thyroid surgery: An international survey. Head Neck 39(7):1296-1305, 2017. e-Pub 2017. PMID: 28493562.
- Maniakas A, Nehme J, Dufour JJ, Saliba I. Delaying partial stapedectomy for otosclerosis: effects on long-term hearing outcomes following surgery. Eur Arch Otorhinolaryngol 272(7):1605-11, 2015. e-Pub 2015. PMID: 24609646.
- Benamira LZ, Maniakas A, Alzahrani M, Saliba I. Common features in patients with superior canal dehiscence declining surgical treatment. J Clin Med Res 7(5):308-14, 2015. e-Pub 2015. PMID: 25780478.
- Saliba I, Maniakas A, Benamira LZ, Nehme J, Benoit M, Montreuil-Jacques V. Superior canal dehiscence syndrome: clinical manifestations and radiologic correlations. Eur Arch Otorhinolaryngol 271(11):2905-14, 2014. e-Pub 2014. PMID: 24162764.
- Maniakas A, Moubayed SP, Ayad T, Guertin L, Nguyen-Tan PF, Gologan O, Soulieres D, Christopoulos A. North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma. Oral Oncol 50(10):942-6, 2014. e-Pub 2014. PMID: 25096827.
- Saliba J, Payne RJ, Varshney R, Sela E, Maniakas A, Rahme E, Mlynarek A, Caglar D, Hier MP, Tamilia M. Sentinel Lymph Node Biopsy Status Correlates with Postoperative Stimulated Thyroglobulin Levels in Low-risk Papillary Thyroid Cancer Patients. Endocr Pract 20(5):399-404, 2014. e-Pub 2014. PMID: 24325994.
- Maniakas A, Forest VI, Jozaghi Y, Saliba J, Hier MP, Mlynarek A, Tamilia M, Payne RJ. Tumor classification in well-differentiated thyroid carcinoma and sentinel lymph node biopsy outcomes: a direct correlation. Thyroid 24(4):671-4, 2014. e-Pub 2014. PMID: 24199963.
- Maniakas A, Desrosiers M. Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit. Am J Rhinol Allergy 28(2):151-5, 2014. e-Pub 2014. PMID: 24598145.
Review Articles
- Hamidi S, Maniakas A, Cabanillas ME. Advances in Anaplastic Thyroid Cancer Treatment. Endocrinol Metab Clin North Am 54(3):361-375, 2025. e-Pub 2025. PMID: 40716892.
- Hamidi S, Maniakas A, Cabanillas ME. Advances in Anaplastic Thyroid Cancer Treatment. Endocrinology and Metabolism Clinics of North America, 2025.
- Cabanillas ME, Akhave N, Banuchi V, Busaidy N, Dadu R, Ferrarotto R, Gunn GB, Hamidi S, Hofmann MC, Hosseini SM, Iyer PC, Lai SY, Lee A, Maniakas A, Ning MS, Spiotto M, Wang JR, Williams MD, Zafereo M. Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure. Thyroid 35(5):462-470, 2025. e-Pub 2025. PMID: 40388579.
- Hamidi S, Maniakas A. Recent advances in anaplastic thyroid cancer management. Curr Opin Endocrinol Diabetes Obes 30(5):259-264, 2023. e-Pub 2023. PMID: 37410453.
- Tasoulas J, Srivastava S, Xu X, Tarasova V, Maniakas A, Karreth FA, Amelio AL. Genetically engineered mouse models of head and neck cancers. Oncogene 42(35):2593-2609, 2023. e-Pub 2023. PMID: 37474617.
- Maniakas A, Zafereo M, Cabanillas ME. Anaplastic Thyroid Cancer: New Horizons and Challenges. Endocrinol Metab Clin North Am 51(2):391-401, 2022. e-Pub 2022. PMID: 35662448.
- Zagury-Orly I, Khaouam N, Noujaim J, Desrosiers MY, Maniakas A. The Effect of Radiation and Chemoradiation Therapy on the Head and Neck Mucosal Microbiome: A Review. Front Oncol 11:784457, 2021. e-Pub 2021. PMID: 34926301.
- Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E Jr, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, Yao CMKL, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Wesson RA, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck 42(6):1194-1201, 2020. e-Pub 2020. PMID: 32342541.
- Maniakas A, Davies L, Zafereo ME. Thyroid Disease Around the World. Otolaryngol Clin North Am 51(3):631-642, 2018. e-Pub 2018. PMID: 29548512.
- Maniakas A, Saliba I. Neurofibromatosis type 2 vestibular schwannoma treatment: a review of the literature, trends, and outcomes. Otol Neurotol 35(5):889-94, 2014. e-Pub 2014. PMID: 24675066.
Other Articles
- Marczyk VR, Fazeli S, Dadu R, Busaidy NL, Iyer P, Hu MI, Sherman SI, Hamidi S, Hosseini SM, Williams MD, Ahmed S, Routbort MJ, Luthra R, Roy-Chowdhuri S, San Lucas FA, Patel KP, Hong DS, Zafereo M, Wang JR, Maniakas A, Waguespack SG, Cabanillas ME Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy. JCO Precis Oncol 9:e2500552, 2025. PMID: 40632979.
- Sioufi K, Haynes AD, Gidley PW, Maniakas A, Roberts D, Nader ME Survival Outcomes of Temporal Bone Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg 171(1):1-10, 2024. PMID: 38341629.
- É G, Maniakas A, Saliba I Meta-analysis on the clinical outcomes in patients with intralabyrinthine schwannomas: conservative management vs. microsurgery. Eur Arch Otorhinolaryngol 273(6):1357-67, 2016. PMID: 25673023.
- Maniakas A, Saliba I Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Otol Neurotol 33(9):1611-20, 2012. PMID: 22996165.
- Maniakas A, Saliba I Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Otol Neurotol 33(2):230-8, 2012. PMID: 22222572.
Editorials
- Cumbo F, Joshi J, Thurnher D, Maniakas A. Editorial: The role of the microbiome in head and neck cancer. Front Oncol 15:1545067, 2025. PMID: 39895695.
Abstracts
- Maniakas A, Gillenwater A, Cognetti D, Mifsud M, Ashraf N, Civantos F, Danesi H, Veresh B, Chen SE, Dong H, Larracas C, Arnold S. A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC). 2025 ASCO Annual Meeting, 2025. e-Pub 2025.
- Zafereo M, Wang J, Busaidy N, Dadu R, Iyer P, Waguespack S, Xu L, Maniakas A, Banuchi V, Lai S, Chinn S, Geiger J, Kerrigan K, Khan S, Moore E, Ryder M, Scharpf J, Worden F, Williams M, Cabanillas M. Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for BRAF V600E-mutated anaplastic thyroid cancer (BRAFm-ATC): A multicenter phase 2 trial. 2025 ASCO Annual Meeting, 2025. e-Pub 2025.
- Abubaker A, Miller M, Henderson Y, Meyers B, Feng N, Wang S, Molkentine J, Zuniga A, Giuliana V, Lai S, Terranova C, Maniakas A. Development and characterization of BRAF/MEK inhibitor resistant anaplastic thyroid carcinoma patient-derived xenograft and cell line models. 2025 AACR Annual Meeting, 2025. e-Pub 2025.
- Abubaker A, Henderson Y, Hofmann M, Busaidy N, Cabanillas M, Williams M, Maniakas A, Lai S. Novel anaplastic thyroid carcinoma patient-derived xenograft models and cell line. 2025 AACR Annual Meeting, 2025. e-Pub 2025.
- Cabanillas, M, Busaidy, N, Iyer, P, Gule-Monroe, M, Gunn, G, Spiotto, M, Akhave, N, Sousa, L, Ferrarotto, R, Zafereo, M, Wang, J, Maniakas A, Williams, M, Liu, S, Fellman, B, Hamidi, S, Dadu, R. Adjuvant pembrolizumab (pembro) after multimodal therapy for anaplastic thyroid cancer (ATC). 2024 American Thyroid Association Annual Meeting, 2024. e-Pub 2024.
- Cubb, T, Busaidy, N, Hamidi, S, Gule-Monroe, M, Iyer, P, Shaw, K, Roy Chowdhuri, S, Sura, G, Zafereo, M, Wang, J, Banuchi, V, Maniakas A, Cabanilla, M. Effect of PI3K pathway activating mutations (PI3Kpath-mutation) on response to BRAF/MEK inhibitor (BRAF/MEKi) therapy in BRAFV600E mutated anaplastic thyroid cancer (BRAFV600Em-ATC). 2024 American Thyroid Association Annual Meeting, 2024. e-Pub 2024.
- Vodopivec D, Cabanillas ME, Busaidy NL, Gule-Monroe M, Zafereo ME, Wang JR, Williams MD, Waguespack SG, Bassett R, Maniakas A, Lai SY, Dadu R. PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer 6(1):A848–A849, 2022. e-Pub 2022.
- Renteria AE, Maniakas A, Filali-Mouhim A, Cardoso FV, Brochiero E, Adam D, Gonzalez E, Mfuna Endam L, Pelletier A, Desrosiers M. Engineering for success after ESS: Decrease in T1 inflammation, epithelial restoration, and reduction in S. aureus. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting, 2022. e-Pub 2022.
- Renteria AE, Maniakas A, Filali-Mouhim A, Cardoso FV, Brochiero E, Mfuna Endam L, Pelletier A, Desrosiers M. Azithromycin reduces type 1 inflammation and induces epithelial restoration after ESS. American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting, 2022. e-Pub 2022.
- Maniakas A, Sullivan A, Busaidy N, Cabanillas M, Dadu R, Fisher S, Graham P, Gross N, Grubbs E, Gunn B, Hu M, Li Z, Perrier N, Waguespack S, Wang J, Williams M, Zafereo M. Decreasing indications for postoperative adjuvant radiation therapy in locoregionally-advanced medullary thyroid cancer. Thyroid 31(S1):A107, 2021. e-Pub 2021.
- Maniakas A, Henderson Y, Hei H, Kalu NN, Peng S, Bell D, Williams MD, Nikiforov YE, Scherer S, Wheeler DA, Clayman GL, Johnson FM, Lai SY. In vivo drug response evaluation in anaplastic thyroid cancer patient-derived tumor xenografts following high-throughput screening. Proceedings of the 111th Annual Meeting of the American Association for Cancer Research(A1662), 2020. e-Pub 2020.
- Sperling J, Maniakas A, Goswami M, Cote G, Dadu R, Busaidy NL, Lai SY, Gross N, Goepfert R, Sturgis E, Zafereo M, Cabanillas ME, Wang JR. Prior cancers among patients newly diagnosed with anaplastic thyroid carcinoma: prevalence and impact on survival. Thyroid 29(S1):A185, 2019. e-Pub 2019.
- Maniakas A, Dadu R, Wang JR, Busaidy NL, Hofmann MC, Sperling J, Gross N, Sturgis E, Goepfert R, Lai SY, Cabanillas ME, Zafereo M. Revolutionizing the therapeutic landscape of a deadly disease. Thyroid 29(S1):A180, 2019. e-Pub 2019.
- Yang N, Boudoux C, De Montigny E, Maniakas A, Sharmila K, Madore J, Gologan O, Guertin L, Christopoulos A, Bissada E, Ayad T. Rapid Tissue Identification in Thyroid Surgery using Optical Coherence Tomography. Thyroid 28(S1):A50, 2018. e-Pub 2018.
- Samargandy S, Leslie WD, Rajaraman M, Li L, Zahedi A, Jefford C, McGibbon A, Young JEM, Pathak KA, Badreddine M, De Brabandere S, Fong H, Pasternak J, Maniakas A, Shariff SZ, Van Uum S. Impact of socioeconomic status on thyroid cancer presentation and outcome: a retrospective multicenter cohort study. Thyroid 28(S1):A192, 2018. e-Pub 2018.
- Pathak A, Singarayer R, Leslie WD, Rajaraman M, Maniakas A, Jefford C, McGibbon A, Young JEM, Zahedi A, Bureau Y, Badreddine M, De Brabandere S, Fong H, Van Uum S. Regional variation in initial surgical treatment of well-differentiated thyroid cancer: Is there an impact on recurrence?. Thyroid 27(S1):A180, 2017. e-Pub 2017.
- Renteria AE, Mfuna Endam L, Lariviere F, Maniakas A, Nayan S, Desrosiers M. Elderly patients with chronic sinusitis have increased sinus dysbiosis(157):P159, 2017. e-Pub 2017.
- Maniakas A, De Montigy E, Christopoulos A, Bissada E, Gologan OE, Boudoux C, Ayad T. Rapid tissue optical biopsy in thyroid and parathyroid surgery(155):P172, 2016. e-Pub 2016.
- Maniakas A, De Montigy E, Madore WJ, Christopoulos A, Bissada E, Guertin L, Tabet JC, Gologan OE, Boudoux C, Ayad T. In vivo rapid tissue identification with optical coherence tomography in thyroid and parathyroid surgery. Thyroid 26(S1):A79, 2016. e-Pub 2016.
- Maniakas A, Asmar MH, Renteria Flores AE, Nayan S, Alromaih S, Mfuna Endam L, Desrosiers M. Real life trial in high-risk chronic rhinosinusitis patients:A141, 2016. e-Pub 2016.
- Maniakas A, Christopoulos A, Bissada E, Guertin L, Olivier MJ, Malaise J, Ayad T. International survey on peri-operative practices in thyroid surgery(155):P171, 2016. e-Pub 2016.
- Asmar MH, Gaudreau A, Maniakas A, Mfuna Endam L, Desrosiers M. An evaluation of SPARC protein as a serum biomarker of EMT transition in CRS(155):P148, 2016. e-Pub 2016.
- Maniakas A, Asmar MH, Kilty S, Al-Felasi M, Mfuna Endam L, Desrosiers M. Eustachian tube symptoms are frequent in CRS and respond well to ESS(155):P148, 2016. e-Pub 2016.
- Maniakas A, Christopoulos A, Bissada E, Guertin L, Olivier MJ, Malaise J, Boucher A, Rondeau G, Ayad T. Peri-operative practices in thyroid surgery: an international survey. Thyroid 25(S1):A265, 2015. e-Pub 2015.
- Maniakas A, Nayan S, Mfuna Endam L, Desrosiers M. Cost effective selection between swab and tissue biopsy for conventional sinus cultures in chronic rhinosinusitis patients(A47), 2015. e-Pub 2015.
- Nayan S, Maniakas A, Mfuna Endam L, Desrosiers M. Risk factors for failure in the surgical management of frontal sinusitis in cystic fibrosis patients(A90), 2015. e-Pub 2015.
- Saliba I, Gosselin E, Maniakas A. Méta-analyse sur les issues cliniques du traitement conservateur versus chirurgical pour les schwannomes intralabyrinthiques 131(4):A57, 2014. e-Pub 2014.
- Saliba I, Benamira Z, Maniakas A, Alzahrani M. Syndrome de déhiscence du canal supérieur : profil clinique et audiométrique des patients qui ne requièrent pas un traitement chirurgical 130(4):A87, 2013. e-Pub 2013.
- Maniakas A, Moubayed SP, Ayad T, Guertin L, Nguyen-Tan PF, Gologan OE, Soulieres D, Christopoulos A. North American Survey on HPV and p16 testing in head and neck cancer(149):P181, 2013. e-Pub 2013.
- Saliba I, Benamira Z, Maniakas A, Alzahrani M. Preoperative features in superior canal dehiscent patients who do not need a surgical treatment. American Neurotology Society:SP12, 2013. e-Pub 2013.
- Maniakas A, Saliba I. Radiothérapie stéréotaxique versus microchirurgie pour les schwannomes vestibulaires : une méta-analyse de patients ayant plus de cinq ans de suivi 129(4):A33, 2012. e-Pub 2012.
- Maniakas A, Saliba J, Hier MP, Mlynarek A, Caglar D, Tamilia M, Payne RJ. Preoperative thyroglobulin levels and sentinel lymph node biopsy outcomes in well differentiated thyroid carcinoma: Is there a correlation?. Otolaryngology-Head and Neck Surgery:SP253, 2012. e-Pub 2012.
- Maniakas A, Saliba J, Hier MP, Mlynarek A, Caglar D, Tamilia M, Payne RJ. Tumor classification in Well Differentiated Thyroid Carcinoma and Sentinel Lymph Node Biopsy Outcomes: a Direct Correlation. Thyroid 22(S1):A65, 2012. e-Pub 2012.
- Maniakas A, Desrosiers M. Effectiveness of azithromycin as an add-on therapy to steroid irrigations in high-risk post-endoscopic sinus surgery patients:A19, 2012. e-Pub 2012.
- Maniakas A, Saliba I. Gestion conservatrice versus radiochirurgie pour les schwannomes vestibulaires : une méta-analyse de patients ayant plus de 5 ans de suivi 128(4):A69, 2011. e-Pub 2011.
- Liang F, Danialou G, Maniakas A, Yim S, Bourdon J, Petrof BJ. Genetic ablation of CC Family Chemokine Receptor 2 (CCR2) mitigates muscle dysfunction in the dystrophic (Mdx) mouse diaphragm(179):A6132, 2009. e-Pub 2009.
Book Chapters
- Maniakas A, Zafereo M, Cabanillas ME. Anaplastic Thyroid Cancer: new Horizons and Challenges. In: Updates in Thyroidology. Elsevier, 2022.
- Maniakas A, Chen A, Chiang FY, Zafereo M. Lateral neck dissection: Indications and technique. In: Randolph: Surgery of the Thyroid and Parathyroid Glands. 3. Elsevier, 2020.
- Wiseman K, Maniakas A. Legal, Ethical & Socioeconomic Issues in Plastic Surgery. In: Facial plastic and reconstructive surgery - High-yield board review. 1. JP Medical Inc, 2019.
- Voizard B, Maniakas A. Otoplasty. In: Facial plastic and reconstructive surgery - High-yield board review. 1. JP Medical Inc, 2019.
- Maniakas A, Davies L, Zafereo M. Thyroid Disease around the world. In: Global Health in Otolaryngology: Otolaryngologic Clinics of North America. Elsevier, 2018.
- Maniakas A, Christopoulos A. Cancer of the cervical esophagus. In: Eugene Myers Operative Otolaryngology - Head and Neck Surgery. 3. Elsevier, 2017.
Letters to the Editor
- Maniakas A, Hu MI, Gunn GB, Zafereo M. Reply to Letter to the Editor regarding "Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer". Head Neck 46: 1848-1849, 2024.
Patient Reviews
CV information above last modified October 09, 2025